In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain

Progesterone receptor plays an important role in the progression of breast cancer. Currently, antibody-based Immunohistochemistry is used in pathological assessment of PR levels for the detection of breast cancer. The shortcomings associated with antibodies pave the path to use aptamers as the al...

Full description

Bibliographic Details
Main Author: Nadhan, Navien Tholasi
Format: Thesis
Language:English
Published: 2022
Subjects:
Online Access:http://eprints.usm.my/59309/1/NAVIEN%20AL%20THOLASI%20NADHAN%20-%20TESIS%20cut.pdf
_version_ 1797014247265271808
author Nadhan, Navien Tholasi
author_facet Nadhan, Navien Tholasi
author_sort Nadhan, Navien Tholasi
collection USM
description Progesterone receptor plays an important role in the progression of breast cancer. Currently, antibody-based Immunohistochemistry is used in pathological assessment of PR levels for the detection of breast cancer. The shortcomings associated with antibodies pave the path to use aptamers as the alternatives. Aptamers are single-stranded DNA or RNA oligonucleotides generated by SELEX that are capable of binding to their cognate target molecules with high affinity and specificity based on their unique structural folding capacity. The tediousness and rigor associated with certain steps of the conventional SELEX intensify the efforts to select DNA aptamers using in silico-docking approach. That said, we report an in silico selection and validation of DNA aptamer to the progesterone receptor DNA binding domain (PR DBD) using ssDNA sequences derived from human progesterone response elements (PREs). Firstly, a library of sixty-four different nearnative ssDNA analogs of the corresponding PRE sequences was designed and subjected to secondary and tertiary structural determination. After that, docking between the ssDNA tertiary structures with the PR DBD was carried out using PatchDock. The sequence with the highest docking score was chosen as the aptamer candidate and further validated by in vitro direct ELASA. Among the candidates, we selected the ssDNA sequence (PRDBDapt17; 5′- AGAACAGCGTGTTCT -3′), which showed the highest docking scores of 11334 as a promising PR DBD binding aptamer. In addition, the PRDBDapt17 detected recombinant PR DBD in direct ELASA with a limit of detection of 3.91 nM.
first_indexed 2024-03-06T16:13:24Z
format Thesis
id usm.eprints-59309
institution Universiti Sains Malaysia
language English
last_indexed 2024-03-06T16:13:24Z
publishDate 2022
record_format dspace
spelling usm.eprints-593092023-09-01T02:29:33Z http://eprints.usm.my/59309/ In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain Nadhan, Navien Tholasi R5-130.5 General works Progesterone receptor plays an important role in the progression of breast cancer. Currently, antibody-based Immunohistochemistry is used in pathological assessment of PR levels for the detection of breast cancer. The shortcomings associated with antibodies pave the path to use aptamers as the alternatives. Aptamers are single-stranded DNA or RNA oligonucleotides generated by SELEX that are capable of binding to their cognate target molecules with high affinity and specificity based on their unique structural folding capacity. The tediousness and rigor associated with certain steps of the conventional SELEX intensify the efforts to select DNA aptamers using in silico-docking approach. That said, we report an in silico selection and validation of DNA aptamer to the progesterone receptor DNA binding domain (PR DBD) using ssDNA sequences derived from human progesterone response elements (PREs). Firstly, a library of sixty-four different nearnative ssDNA analogs of the corresponding PRE sequences was designed and subjected to secondary and tertiary structural determination. After that, docking between the ssDNA tertiary structures with the PR DBD was carried out using PatchDock. The sequence with the highest docking score was chosen as the aptamer candidate and further validated by in vitro direct ELASA. Among the candidates, we selected the ssDNA sequence (PRDBDapt17; 5′- AGAACAGCGTGTTCT -3′), which showed the highest docking scores of 11334 as a promising PR DBD binding aptamer. In addition, the PRDBDapt17 detected recombinant PR DBD in direct ELASA with a limit of detection of 3.91 nM. 2022-08 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/59309/1/NAVIEN%20AL%20THOLASI%20NADHAN%20-%20TESIS%20cut.pdf Nadhan, Navien Tholasi (2022) In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain. Masters thesis, Universiti Sains Malaysia.
spellingShingle R5-130.5 General works
Nadhan, Navien Tholasi
In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain
title In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain
title_full In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain
title_fullStr In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain
title_full_unstemmed In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain
title_short In Silico Selection And Validation Of Dna Aptamer Against Progesterone Receptor Dna Binding Domain
title_sort in silico selection and validation of dna aptamer against progesterone receptor dna binding domain
topic R5-130.5 General works
url http://eprints.usm.my/59309/1/NAVIEN%20AL%20THOLASI%20NADHAN%20-%20TESIS%20cut.pdf
work_keys_str_mv AT nadhannavientholasi insilicoselectionandvalidationofdnaaptameragainstprogesteronereceptordnabindingdomain